Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ura

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Endocrinologia Japonica|October 1, 1989
A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatmentK Matsuda, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|May 1, 1982
Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertensionK Kikuchi, A Miyama, T Nakao, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Comprehensive studies on the renal kallikrein-kinin system in essential hypertensionY Nakahashi, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|September 1, 1981
Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseasesK Shimamoto, N Ura, S Tanaka, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humansK Shimamoto, M Nakagawa, S Fukuyama, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Renal kininases in primary aldosteronismN Ura, K Shimamoto, H Ogata, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1987
Plasma levels of human atrial natriuretic peptide in patients with hypertensive diseasesO Iimura, K Shimamoto, T Ando, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The renal kallikrein-kinin system in renoparenchymal hypertensionT Ando, K Shimamoto, N Ura, et al.
Agents and Actions. Supplements|January 1, 1987
The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertensionO Iimura, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|October 1, 1983
The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertensionK Shimamoto, T Nakao, N Ura, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Endocrinologia Japonica|October 1, 1989
A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatmentK Matsuda, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|May 1, 1982
Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertensionK Kikuchi, A Miyama, T Nakao, et al.
Advances in Experimental Medicine and Biology|January 1, 1986
Comprehensive studies on the renal kallikrein-kinin system in essential hypertensionY Nakahashi, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|September 1, 1981
Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseasesK Shimamoto, N Ura, S Tanaka, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humansK Shimamoto, M Nakagawa, S Fukuyama, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Renal kininases in primary aldosteronismN Ura, K Shimamoto, H Ogata, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1987
Plasma levels of human atrial natriuretic peptide in patients with hypertensive diseasesO Iimura, K Shimamoto, T Ando, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The renal kallikrein-kinin system in renoparenchymal hypertensionT Ando, K Shimamoto, N Ura, et al.
Agents and Actions. Supplements|January 1, 1987
The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertensionO Iimura, K Shimamoto, N Ura, et al.
Japanese Circulation Journal|October 1, 1983
The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertensionK Shimamoto, T Nakao, N Ura, et al.
Pageof 9